retatrutide glp-1 medication Some Providers Prescribe Unapproved for Weight Loss at Alarming Rate Retatrutide 10mg — Triple Agonist

This option works well for patients who prefer smaller quantities, who want fresher medication with each refill, or whose prescribers prefer shorter prescription intervals for closer monitoring

225, 2014 [30] S

Clinical Evidence: Anxiety Risk on GLP-1 Receptor Agonists Major semaglutide trials, including STEP and SUSTAIN programs, reported anxiety in fewer than 3% of treatment participantsrates comparable to placebo control groups

310 , R906R916 (2016)

Recalls & Warnings August 19, 2015 Soylent Meal Replacement Powder Reported to Contain Lead and Cadmium On August 13, 2015, an environmental-health watchdog group, As You Sow, filed a notice of intent to bring legal action against Soylent, a "meal replacement" powder, alleging violation of California's "Prop 65" Safe Drinking Water and Toxic Enforcement Act

Availability improved throughout 2024 and 2025, though periodic supply constraints continue affecting some pharmacies and regions